These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 27920543)

  • 1. Intestinal permeability in a patient with liver cirrhosis.
    Aguirre Valadez JM; Rivera-Espinosa L; Méndez-Guerrero O; Chávez-Pacheco JL; García Juárez I; Torre A
    Ther Clin Risk Manag; 2016; 12():1729-1748. PubMed ID: 27920543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal barrier dysfunction in cirrhosis: Current concepts in pathophysiology and clinical implications.
    Tsiaoussis GI; Assimakopoulos SF; Tsamandas AC; Triantos CK; Thomopoulos KC
    World J Hepatol; 2015 Aug; 7(17):2058-68. PubMed ID: 26301048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota-related complications in cirrhosis.
    Gómez-Hurtado I; Such J; Sanz Y; Francés R
    World J Gastroenterol; 2014 Nov; 20(42):15624-31. PubMed ID: 25400446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver cirrhosis and complications from the perspective of dysbiosis.
    Nie G; Zhang H; Xie D; Yan J; Li X
    Front Med (Lausanne); 2023; 10():1320015. PubMed ID: 38293307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FXR modulates the gut-vascular barrier by regulating the entry sites for bacterial translocation in experimental cirrhosis.
    Sorribas M; Jakob MO; Yilmaz B; Li H; Stutz D; Noser Y; de Gottardi A; Moghadamrad S; Hassan M; Albillos A; Francés R; Juanola O; Spadoni I; Rescigno M; Wiest R
    J Hepatol; 2019 Dec; 71(6):1126-1140. PubMed ID: 31295531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut Microbiota and Infectious Complications in Advanced Chronic Liver Disease: Focus on Spontaneous Bacterial Peritonitis.
    Maccauro V; Airola C; Santopaolo F; Gasbarrini A; Ponziani FR; Pompili M
    Life (Basel); 2023 Apr; 13(4):. PubMed ID: 37109520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial translocation and its consequences in patients with cirrhosis.
    Guarner C; Soriano G
    Eur J Gastroenterol Hepatol; 2005 Jan; 17(1):27-31. PubMed ID: 15647636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation.
    Nicoletti A; Ponziani FR; Biolato M; Valenza V; Marrone G; Sganga G; Gasbarrini A; Miele L; Grieco A
    World J Gastroenterol; 2019 Sep; 25(33):4814-4834. PubMed ID: 31543676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes of Intestinal Functions in Liver Cirrhosis.
    Fukui H; Wiest R
    Inflamm Intest Dis; 2016 Apr; 1(1):24-40. PubMed ID: 29922655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Physiopathology of bacterial translocation and spontaneous bacterial peritonitis in cirrhosis].
    González Alonso R; González García M; Albillos Martínez A
    Gastroenterol Hepatol; 2007 Feb; 30(2):78-84. PubMed ID: 17335715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the gut-liver-immune axis to treat cirrhosis.
    Tranah TH; Edwards LA; Schnabl B; Shawcross DL
    Gut; 2021 May; 70(5):982-994. PubMed ID: 33060124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal epithelial barrier function in liver cirrhosis: an extensive review of the literature.
    Pijls KE; Jonkers DM; Elamin EE; Masclee AA; Koek GH
    Liver Int; 2013 Nov; 33(10):1457-69. PubMed ID: 23879434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial translocation in patients with liver cirrhosis: physiology, clinical consequences, and practical implications.
    Ponziani FR; Zocco MA; Cerrito L; Gasbarrini A; Pompili M
    Expert Rev Gastroenterol Hepatol; 2018 Jul; 12(7):641-656. PubMed ID: 29806487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg.
    Arab JP; Martin-Mateos RM; Shah VH
    Hepatol Int; 2018 Feb; 12(Suppl 1):24-33. PubMed ID: 28550391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological bacterial translocation in cirrhosis: pathophysiology, diagnosis and clinical implications.
    Bellot P; Francés R; Such J
    Liver Int; 2013 Jan; 33(1):31-9. PubMed ID: 23121656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leaky Gut and Gut-Liver Axis in Liver Cirrhosis: Clinical Studies Update.
    Fukui H
    Gut Liver; 2021 Sep; 15(5):666-676. PubMed ID: 33071239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical impact of microbiome in patients with decompensated cirrhosis.
    Oikonomou T; Papatheodoridis GV; Samarkos M; Goulis I; Cholongitas E
    World J Gastroenterol; 2018 Sep; 24(34):3813-3820. PubMed ID: 30228776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial translocation markers in liver cirrhosis.
    Alexopoulou A; Agiasotelli D; Vasilieva LE; Dourakis SP
    Ann Gastroenterol; 2017; 30(5):486-497. PubMed ID: 28845103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota and probiotics in chronic liver diseases.
    Cesaro C; Tiso A; Del Prete A; Cariello R; Tuccillo C; Cotticelli G; Del Vecchio Blanco C; Loguercio C
    Dig Liver Dis; 2011 Jun; 43(6):431-8. PubMed ID: 21163715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of artesunate supplementation on bacterial translocation and dysbiosis of gut microbiota in rats with liver cirrhosis.
    Chen YX; Lai LN; Zhang HY; Bi YH; Meng L; Li XJ; Tian XX; Wang LM; Fan YM; Zhao ZF; Han DW; Ji C
    World J Gastroenterol; 2016 Mar; 22(10):2949-59. PubMed ID: 26973391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.